Who is sponsoring NCT03892239?

NCT03892239 is sponsored by Universidade Cidade de Sao Paulo.

What drugs are being tested in NCT03892239?

Interventions in NCT03892239: RunIn3 Prevention Program, Feedback Based Surveillance.

What condition does NCT03892239 study?

NCT03892239 studies Running-related Injuries.

Is NCT03892239 still recruiting?

NCT03892239 is currently completed. Last updated 15 October 2021.

Last reviewed 2021-10-15 · How we verify

NCT03892239

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of a Running-related Injury Prevention Program in Runners

Completed NA Last updated 15 October 2021

What this trial tests

NA trial testing RunIn3 Prevention Program in Running-related Injuries in 530 participants. Completed in 8 January 2021.

Timeline

1 April 2019

Primary endpoint
8 January 2021

8 January 2021

Quick facts

Lead sponsor	Universidade Cidade de Sao Paulo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	530
Start date	1 April 2019
Primary completion	8 January 2021
Estimated completion	8 January 2021
Sites	1 location across Brazil

Drugs / interventions tested

RunIn3 Prevention Program
Feedback Based Surveillance

Conditions studied

Running-related Injuries — all drugs for Running-related Injuries →

Sponsor

Universidade Cidade de Sao Paulo

Who can join

18 and older, any sex, with Running-related Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Running is effective in increasing levels of physical activity and promotes a number of beneficial health effects. However, running can lead to running- related injuries (RRI). In theory, such injuries can be avoided with the implementation of prevention programs. But in practice, there is a paucity of prevention programs that are effective in reducing the risk of RRIs. In a previous study, the investigators developed an RRI prevention program using the Intervention Mapping framework. The RRI prevention program was named RunIn3. The present study will evaluate the effectiveness of the RunIn3 RRI prevention program. Objective: To investigate the effectiveness of an RRI prevention program (i.e., RunIn3). There will be recruited 530 runners of the state of São Paulo aged 18 years or older. After inclusion, participants will be randomly assigned and allocated in two groups: (1) intervention group, which will be the target of the implementation of the RunIn3 prevention program; and (2) control group, which will receive a minimal intervention (i.e., feedback based on surveillance).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

RunIn3: the development process of a running-related injury prevention programme.
Vallio CS, de Oliveira GM, Mota GAK, Lopes AD, et al · · 2021 · cited 6× · PMID 34306726 · DOI 10.1136/bmjsem-2021-001051
Cost-effectiveness and implementation process of a running-related injury prevention program (RunIn3): Protocol of a randomized controlled trial.
Barros PM, Vallio CS, Oliveira GM, Miyamoto GC, et al · · 2021 · cited 3× · PMID 33553800 · DOI 10.1016/j.conctc.2021.100726

Verify or expand the search:

Other Universidade Cidade de Sao Paulo trials

Trials by the same sponsor.

NCT05904925 — Pilates for the Prevention of Musculoskeletal Complaints During Pregnancy · NA · unknown
NCT05575089 — Inspiratory Muscle Training and Pulmonary Function in Patients Submitted to Bariatric Surgery · NA · completed
NCT04274439 — Effectiveness and Cost-Effectiveness of a Tele-Rehabilitation Program in the Treatment of Chronic Musculoskeletal Pain · NA · unknown
NCT04114422 — A Seven-day Preoperative Exercise Training Program in People With Abdominal Cancer · NA · withdrawn
NCT03896672 — Clinical Implementation of the Use of Positive Pressure in Chest Drainage · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03892239 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Cidade de Sao Paulo
Last refreshed: 15 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03892239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing